W. Nichols

发表

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

K. Doheny, E. Pugh, J. Gusella, 2009, Human Genetics.

Genetic basis of pulmonary arterial hypertension: current understanding and future directions.

J. Knowles, R. Trembath, B. Janssen, 2004, Journal of the American College of Cardiology.

Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

J. Newman, J. Phillips, J. Loyd, 2003, American journal of respiratory and critical care medicine.

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family

M. Humbert, P. Corris, J. Egan, 2000, Journal of medical genetics.

Moderation of hemophilia A phenotype by the factor V R506Q mutation.

R. Kaufman, D. Ginsburg, K. Michaelides, 1996, Blood.

Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension

W. Chung, Yufeng Shen, M. Humbert, 2019, bioRxiv.

Von Willebrand disease.

D. Ginsburg, W. Nichols, J. Robertson, 2008, Pediatric clinics of North America.

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia

Tatiana Foroud, Nathan Pankratz, T. Foroud, 2006, Movement disorders : official journal of the Movement Disorder Society.

High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study

R. Kaufman, M. Morris, A. Thompson, 2012 .

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

W. Chung, Yufeng Shen, Yicheng Guo, 2020, bioRxiv.

Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

W. Chung, S. Fahn, H. Rana, 2014, JAMA neurology.

Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension

W. Chung, Yufeng Shen, M. Humbert, 2019, bioRxiv.

The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study

J. Nutt, K. Marder, M. Rezak, 2015, Movement disorders : official journal of the Movement Disorder Society.

Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease.

N. D. Arnold, K. Lunetta, M. Boehnke, 1996, Blood.

Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension

M. Humbert, D. Trégouët, I. Prokopenko, 2019, European Respiratory Journal.

Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122).

J. Liepnieks, M. Benson, E. Snyder, 1991, The Journal of laboratory and clinical medicine.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Ouwehand, 2018, bioRxiv.

Reduced transfer coefficient of carbon monoxide in pulmonary arterial hypertension implicates rare protein-truncating variants in KDR

Yufeng Shen, K. Megy, S. Gräf, 2019 .

The EYA3 tyrosine phosphatase activity promotes pulmonary vascular remodeling in pulmonary arterial hypertension

R. Hegde, J. Molkentin, K. Wikenheiser-Brokamp, 2019, Nature Communications.

Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?

R. Pyeritz, J. Ryu, J. Cogan, 2007, Chest.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Ouwehand, 2018, bioRxiv.

Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension

D. Ivy, R. Damico, A. Everett, 2021, Journal of the American Heart Association.

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8

T. Foroud, A. Rudolph, N. Pankratz, 2007, Neurology.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

M. Nalls, A. Singleton, T. Wolfsberg, 2013, JAMA neurology.

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension

R. Kittles, M. Humbert, L. Harbaum, 2021, European Respiratory Journal.

Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis.

M. Benson, W. Nichols, E. D. Gordon, 1991, American journal of medical genetics.

Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification.

V. McKusick, J. Liepnieks, M. Benson, 1989, Genomics.

Chronic Allergic Inflammation Causes Vascular Remodeling and Pulmonary Hypertension in Bmpr2 Hypomorph and Wild-Type Mice

T. L. Le Cras, W. Nichols, M. Pauciulo, 2012, PloS one.

The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.

K. Cooney, H. Gralnick, D. Ginsburg, 1991, The Journal of clinical investigation.

Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.

R. Cody, D. Ginsburg, W. Nichols, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

M. Farrer, L. Warren, R. Uitti, 2006, Archives of neurology.

Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease

T. Foroud, A. Rudolph, N. Pankratz, 2006, Movement disorders : official journal of the Movement Disorder Society.

Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease.

B. Funalot, J. Pérez-Tur, W. Nichols, 2006, Genetic testing.

Glucocerebrosidase enzyme activity in GBA mutation Parkinson’s disease

R. Saunders-Pullman, L. Severt, S. Boschung, 2016, Journal of Clinical Neuroscience.

Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers

S. Bressman, M. Zimmerman, R. Saunders-Pullman, 2021, Frontiers in Neurology.

Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.

R. Damico, A. Everett, E. Austin, 2020, The Journal of pediatrics.

A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia.

J. Haddow, J. Liepnieks, M. Benson, 1990, The Journal of clinical investigation.

Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension.

Lisa J. Martin, R. Damico, P. Hassoun, 2020, Chest.

Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay.

W. Chung, Xiwen Ma, Z. Gan-Or, 2017, Molecular genetics and metabolism.

Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension

Lisa J. Martin, R. Damico, P. Hassoun, 2020, European Respiratory Journal.

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.

J. Knowles, D. Gail, S. Archer, 2004, Circulation.

Genetics and genomics of pulmonary arterial hypertension

W. Chung, R. Trembath, N. Morrell, 2019, European Respiratory Journal.

Mutations in the Tgfβ Superfamily Receptors, BMPR2 and ALK-1 , Cause Pulmonary Hypertension

M. Humbert, R. Trembath, J. Loyd, 2001 .

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome

M. Dunning, M. Humbert, D. Trégouët, 2020, American journal of respiratory and critical care medicine.

MURINE PULMONARY RESPONSE TO CHRONIC HYPOXIA IS STRAIN SPECIFIC

J. Harral, T. Kuriyama, James West, 2008, Experimental lung research.

Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation

K. Marder, L. Cote, J. Vonsattel, 2014, Movement disorders : official journal of the Movement Disorder Society.

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

S. Anderson, K. Marder, M. Welter, 2022, Annals of neurology.

Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults

W. Chung, Yufeng Shen, F. Dewey, 2018, Circulation. Genomic and precision medicine.

Conserved linkage of neurotrophin-3 and von Willebrand factor on mouse Chromosome 6

K. Mohlke, M. Meisler, D. Ginsburg, 2004, Mammalian Genome.

von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene.

K. Cooney, K. Mohlke, D. Ginsburg, 1995, Blood.

Combined factors V and VIII deficiency — the solution

R. Kaufman, C. Kessler, D. Ginsburg, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction.

D. Ginsburg, W. Nichols, P. Cacheris, 1991, The Journal of biological chemistry.

Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.

M. Medvedovic, J. Whitsett, W. Hardie, 2007, American journal of respiratory cell and molecular biology.

High frequency of BMPR 2 exonic deletions / duplications in familial pulmonary arterial hypertension

J. Cogan, J. Phillips, J. Loyd, 2006 .

Neonatal purpura fulminans in association with factor V R506Q mutation.

A. Schmaier, D. Ginsburg, S. Pipe, 1996, The Journal of pediatrics.

Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32

N. D. Arnold, Daniel L. Koller, T. Foroud, 1997, Nature Genetics.

A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11.

K. Cooney, K. Mohlke, R. Westrick, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The molecular basis of von Willebrand disease

K. Mohlke, D. Ginsburg, W. Nichols, 1999, International journal of clinical & laboratory research.

von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene [published erratum appears in Blood 1995 Sep 15;86(6):2461]

K. Cooney, K. Mohlke, D. Ginsburg, 1994 .

Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.

W. Chung, P. Mazzoni, K. Marder, 2015, Brain : a journal of neurology.

Production of an antibody to mouse salivary androgen binding protein (ABP) and its use in identifying a prostate protein produced by a gene distinct from Abp

W. Nichols, R. C. Karn, S. Dlouhy, 1986, Biochemical Genetics.

Racial and ethnic differences in pulmonary arterial hypertension

J. Paulus, W. Nichols, S. Kawut, 2017, Pulmonary circulation.

Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

R. Trembath, J. Phillips, J. Loyd, 2000, Nature Genetics.

von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene.

K. Cooney, K. Mohlke, D. Ginsburg, 1994, Blood.

Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.

J. Liepnieks, M. Benson, W. Nichols, 1988, Biochemical and biophysical research communications.

ST2 is a biomarker of pediatric pulmonary arterial hypertension severity and clinical worsening.

R. Damico, A. Everett, E. Austin, 2021, Chest.

Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

L. Seeberger, K. Marder, D. Jennings, 2003, Neurology.

From the ER to the golgi: insights from the study of combined factors V and VIII deficiency.

D. Ginsburg, W. Nichols, 1999, American journal of human genetics.

High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension.

J. Wansapura, G. Kato, P. Malik, 2010, Blood.

Brief report High levels of placenta growth factor in sickle cell disease promote pulmonary

J. Wansapura, G. Kato, P. Malik, 2010 .

Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex

R. Kaufman, D. Ginsburg, S. Pipe, 2003, Nature Genetics.

Rapid Publication Linkage of Combined Factors V and VIII Deficiency to Chromosome 18 q by Homozygosity Mapping

N. D. Arnold, R. Kaufman, D. Ginsburg, 2013 .

Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping.

N. D. Arnold, R. Kaufman, D. Ginsburg, 1997, The Journal of clinical investigation.

Mutations in the ER–Golgi Intermediate Compartment Protein ERGIC-53 Cause Combined Deficiency of Coagulation Factors V and VIII

H. Hauri, R. Kaufman, D. Ginsburg, 1998, Cell.

Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.

R. Kaufman, D. Ginsburg, Bin Zhang, 2006, Blood.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset

T. Foroud, A. Rudolph, N. Pankratz, 2009, Neurology.

Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study

D. Corcos, L. Verhagen Metman, J. Shils, 2021, Frontiers in Neurology.

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

S. Anderson, K. Marder, M. Welter, 2022 .

A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.

R. Gregg, M. Benson, W. Nichols, 1990, Genomics.

Hereditary amyloidosis: detection of variant prealbumin genes by restriction enzyme analysis of amplified genomic DNA sequences

M. Benson, W. Nichols, William C. Nichols, 1990, Clinical genetics.

Frequency of GBA Variants in Autopsy‐proven Multiple System Atrophy

K. Marder, L. Honig, J. Vonsattel, 2017, Movement disorders clinical practice.

Multiple step pattern as a biomarker in Parkinson disease.

Tatiana Foroud, R. Yee, T. Foroud, 2009, Parkinsonism & related disorders.

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

T. Foroud, S. Shurin, J. McClintick, 2001, Nature.

Prenatal detection of a gene for hereditary amyloidosis.

M. Benson, W. Nichols, L. Padilla, 1989, American journal of medical genetics.

Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension

W. Chung, Yufeng Shen, S. Archer, 2020, Circulation.

Hypoxia‐induced Pulmonary Hypertension in Different Mouse Strains: Relation to Transcriptome

T. L. Le Cras, W. Nichols, M. Pandey, 2019, American journal of respiratory cell and molecular biology.

Mutations in DJ-1 are rare in familial Parkinson disease

T. Foroud, A. Rudolph, N. Pankratz, 2006, Neuroscience Letters.

Genomewide association study for onset age in Parkinson disease

Tatiana Foroud, Nathan Pankratz, Anita L DeStefano, 2009, BMC Medical Genetics.

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

Tatiana Foroud, Nathan Pankratz, Shushant Jain, 2005, The Lancet.

High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension.

J. Cogan, J. Phillips, J. Loyd, 2006, American journal of respiratory and critical care medicine.

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease

W. Chung, Yufeng Shen, F. Dewey, 2018, Genome Medicine.

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseSYMBOL

M. Farrer, J. Kachergus, E. Tolosa, 2008, Neurology.

Midkine Is Regulated by Hypoxia and Causes Pulmonary Vascular Remodeling*

P. Reynolds, J. Whitsett, T. L. Le Cras, 2004, Journal of Biological Chemistry.

United States Pulmonary Hypertension Scientific Registry (USPHSR): Baseline Characteristics.

W. Chung, R. Simms, R. Benza, 2020, Chest.

Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Chung, 2019, Genome Medicine.

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

W. Chung, R. Benza, D. Badesch, 2019, Pulmonary circulation.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

Lisa J. Martin, Keith A. Marsolo, Ferhaan Ahmad, 2018, bioRxiv.

Neuropsychiatric characteristics of GBA-associated Parkinson disease

K. Marder, Nir Giladi, L. Ozelius, 2016, Journal of the Neurological Sciences.

Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors.

B. Lanphear, J. Khoury, W. Nichols, 2003, The Journal of pediatrics.

Translation initiator EIF4G1 mutations in familial Parkinson disease.

Michael K. Hutchinson, P. Lockhart, A. Destée, 2011, American journal of human genetics.

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.

J. Jankovic, K. Marder, W. Weiner, 2003, Human molecular genetics.

Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension

R. Boldrini, M. Griese, E. Austin, 2019, European Respiratory Journal.

A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing

K. Mohlke, A. Rehemtulla, D. Ginsburg, 1996, British journal of haematology.

Familial t(8;15)(p23.3;q22.3): report of two cases with dup(15) (q22.3----qter).

R. Ward, D. Goldstein, W. Nichols, 1987, Journal of Medical Genetics.

Genome-wide scan for a healthy aging phenotype provides support for a locus near D4S1564 promoting healthy aging.

T. Foroud, T. Reed, D. Dick, 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

Verification of Self-Report of Zygosity Determined via DNA Testing in a Subset of the NAS-NRC Twin Registry 40 Years Later

C. Tanner, T. Reed, D. Dick, 2005, Twin Research and Human Genetics.

Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years later.

C. Tanner, T. Reed, D. Dick, 2005, Twin research and human genetics : the official journal of the International Society for Twin Studies.

Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease

T. Foroud, A. Rudolph, T. Reed, 2004, Movement disorders : official journal of the Movement Disorder Society.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations

K. Marder, T. Foroud, A. Rudolph, 2009, Neurology.

Copy Number Variation in Familial Parkinson Disease

Jemma B. Wilk, Anita L. DeStefano, Richard H. Myers, 2011, PloS one.

A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage.

Sampath Prahalad, Carl D Langefeld, Stephen S Rich, 2004, Arthritis and rheumatism.

Significant linkage of Parkinson disease to chromosome 2q36-37.

L. Seeberger, E. Siemers, K. Marder, 2003, American journal of human genetics.

Reliability of reported age at onset for Parkinson's disease

T. Foroud, D. Oakes, C. Halter, 2003, Movement disorders : official journal of the Movement Disorder Society.

Idiopathic and Familial Pulmonary Arterial Hypertension

W. Nichols, G. Deutsch, J. Elwing, 2010 .

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Sanjiv J. Shah, M. Gladwin, G. Beck, 2017, American journal of respiratory and critical care medicine.

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

T. Foroud, A. Rudolph, N. Pankratz, 2002, American journal of human genetics.

Genomic Profile of Matrix and Vasculature Remodeling in TGF-α–Induced Pulmonary Fibrosis

M. Medvedovic, J. Whitsett, W. Hardie, 2007 .

Pulmonary arterial hypertension: Specialists’ knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA

Lisa J. Martin, W. Chung, J. Loyd, 2017, Pulmonary circulation.

A mutation in myotilin causes spheroid body myopathy

T. Foroud, H. Goebel, N. Pankratz, 2005, Neurology.

Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31.

C. Bartram, H. Katus, B. Janssen, 2003, Journal of the American College of Cardiology.

NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.

F. Cheng, J. Loscalzo, M. Cho, 2021, Journal of the American College of Cardiology.

Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.

Jason B. Giles, R. Kittles, H. Tiwari, 2020, American journal of respiratory and critical care medicine.

Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations

P. Mazzoni, K. Marder, L. Cote, 2013, Movement disorders : official journal of the Movement Disorder Society.

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

J. Nutt, K. Marder, M. Rezak, 2014, JAMA neurology.

Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families

L. Seeberger, K. Blindauer, T. Foroud, 2002, Journal of medical genetics.

Variation in GIGYF2 is not associated with Parkinson disease

T. Foroud, A. Rudolph, N. Pankratz, 2009, Neurology.

Alpha‐synuclein and familial Parkinson's disease

T. Foroud, A. Rudolph, N. Pankratz, 2009, Movement disorders : official journal of the Movement Disorder Society.

Clinical correlates of depressive symptoms in familial Parkinson's disease

K. Marder, T. Foroud, A. Rudolph, 2008, Movement disorders : official journal of the Movement Disorder Society.

Hearing impairment susceptibility in elderly men and the DFNA18 locus.

T. Reed, N. Pankratz, W. Nichols, 2006, Archives of otolaryngology--head & neck surgery.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease

T. Foroud, A. Rudolph, D. Simon, 2010, BMC Medical Genetics.

Pediatric Pulmonary Hypertension: Insulin Like Growth Factor Binding Protein 2 is a novel marker associated with disease severity and survival

R. Damico, A. Everett, E. Matsui, 2020, Pediatric Research.

Diagnosis of Maryland/German familial amyloidotic polyneuropathy using allele‐specific, enzymatically amplified, genomic DNA

J. Mendell, M. Benson, Xin-sheng Jiang, 1990, Annals of neurology.

Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension

Lisa J. Martin, R. Damico, P. Hassoun, 2020, European Respiratory Journal.

R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation

T. Foroud, A. Rudolph, N. Pankratz, 2007, Movement disorders : official journal of the Movement Disorder Society.

Genes influencing Parkinson disease onset

T. Foroud, A. Rudolph, N. Pankratz, 2004, Neurology.

A SECOND INITIAL LESION OF SYPHILIS ONE YEAR AFTER THE FIRST

W. Nichols, A. A. Nichols, 1923 .

Genomewide Association Study for Onset Age in Parkinson Disease

J. Gusella, T. Foroud, C. Mariani, 2009 .

Familial t(8;15)(p23-3;q22*3): report of two with dup(15)(q22-3 >qter) cases

D. Goldstein, W. Nichols, C. Palmer, 2022 .

Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Chung, 2019, Genome Medicine.

Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival

D. Ivy, T. Kolb, R. Damico, 2020, BMC Medicine.

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease

W. Chung, Yufeng Shen, F. Dewey, 2018, Genome Medicine.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

M. Nalls, A. Singleton, T. Wolfsberg, 2013, JAMA neurology.

Translation initiator EIF4G1 mutations in familial Parkinson disease.

Michael K. Hutchinson, P. Lockhart, A. Destée, 2011, American journal of human genetics.

Genomewide linkage study of modifiers of LRRK2‐related Parkinson's disease

J. Gusella, T. Foroud, J. Wilk, 2011, Movement disorders : official journal of the Movement Disorder Society.

High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension.

J. Wansapura, G. Kato, P. Malik, 2010, Blood.

Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.

R. Kaufman, D. Ginsburg, Bin Zhang, 2006, Blood.

Multiple step pattern as a biomarker in Parkinson disease.

R. Yee, T. Foroud, M. Weaver, 2009, Parkinsonism & Related Disorders.

' s response to reviews Title : Genomewide Association Study for Onset Age in Parkinson Disease

J. Gusella, T. Foroud, C. Mariani, 2009 .

Bmc Medical Genetics Genomewide Association Study for Onset Age in Parkinson Disease

J. Gusella, T. Foroud, C. Mariani, 2022 .